PT - JOURNAL ARTICLE AU - Liu, Hongliang AU - Cheng, Ningchang TI - Effect of Tai Ji and/or Qigong on Patients with Stable Chronic Obstructive Pulmonary Disease A protocol for meta-analysis and systematic review AID - 10.1101/2023.09.21.23295879 DP - 2023 Jan 01 TA - medRxiv PG - 2023.09.21.23295879 4099 - http://medrxiv.org/content/early/2023/09/22/2023.09.21.23295879.short 4100 - http://medrxiv.org/content/early/2023/09/22/2023.09.21.23295879.full AB - Background Chronic obstructive pulmonary disease (COPD) is a global health problem with high morbidity and mortality. Tai Ji and Qigong are traditional Chinese mediative movements, benefit COPD patient’s physical and mental health.Methods We searched the following twelve databases Web of Science, EBSCO, Medline, EMBASE, Scopus, PubMed, PsycArticles, Psychology and Behavioral Sciences Collection, PsycInfo, CINAHL, Cochrane Library online and Clinical trials from inception to July 2023. Any RCTs managed with Tai Ji and/or Qigong on stable COPD were eligible without age, publishment language and comparison management restrict. Outcome measures comprised pulmonary function, the incidence of acute exacerbation, 6WMD, chronic pain, physical and/or cognitive function, and any assessment of people QoL.Results Our research will update evidence summaries and provide a quantitative and standardized assessment of the effect of Tai Ji and/or Qigong on patients with stable COPD.Conclusion Our research will generate the latest evidence for determining whether Tai Ji and/or Qigong is equivalent to conventional PR.Competing Interest StatementThe authors have declared that no competing interests exist.Funding StatementInclude this sentence at the end of your statement: The funders did not and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Nanjing University of Chinese MedicineI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.Not ApplicableI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Not ApplicableI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Not ApplicableIf the manuscript reports pilot data held in a public repository, include URLs, accession numbers or DOIs. If this information will only be available after acceptance, indicate this by ticking the box below. For example: All files are available from the pubmed database.RCTs=randomized controlled trials6WMD=6-minutes walking distanceQoL=quality of lifeCIs=confidence intervalsCAT=COPD assessment test